(1)
Coates, L.; Gladman, D.; Nash, P.; FitzGerald, O.; Kavanaugh, A.; Rasouliyan, L.; Pricop, L.; Ding, K.; Gaillez, C. Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS)-Related Remission: 2-Year Results from a Phase 3 Study. J of Skin 2018, 2, S17.